Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19
Status:
Active, not recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, parallel-arm, phase II, explorative study investigating the
efficacy and safety of orally administered N-Acetylcysteine (NAC) versus placebo in patients
with history of SARS-Cov-2 infection and residual respiratory impairment.